Lutetate tezuvotide tetraxetan
Lutetate tezuvotide tetraxetan is tetrahydrogenated Tetraxetan. Tetraxetan (DOTA) is a complexing agent that can be used to synthesize contrast agents in oncology medicine.
Product Specifications
UNSPSC
12352209
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Cancer
Smiles
O=C(N[C@@H](C(O)=O)CCCCNC(CCC(NCCC[C@H](C(O)=O)NC(CC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)=O)=O)[C@@H](CNC(C(C=C1)=CC=C1[Si](C(C)(C)C)(F)C(C)(C)C)=O)NC2=[O][Lu+3]345([O-]C6=O)([O-]C7=O)([O-]C8=O)[N]9(C2)CC[N]3(C7)CC[N]4(C6)CC[N]5(C8)CC9
Molecular Formula
C60H92FLuN12O23Si
Molecular Weight
1571.49
References & Citations
[1]WHO Drug Information. Volume 38, No. 2.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
